Last reviewed · How we verify
NCT05745636
Broccoli Seed Extract and Skin Health
NA trial testing Broccoli, mustard, vitamin C in Skin Inflammation in 24 participants. Completed in 30 July 2023.
30 July 2023
Quick facts
| Lead sponsor | Appalachian State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 24 |
| Start date | 13 March 2023 |
| Primary completion | 30 July 2023 |
| Estimated completion | 30 July 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Broccoli, mustard, vitamin C
- Placebo
Conditions studied
- Skin Inflammation — all drugs for Skin Inflammation →
Sponsor
Appalachian State University
Who can join
Adults 25 to 57, any sex, with Skin Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to examine the influence of 4-weeks ingestion of TrueBroc®, (broccoli seed extract, BSE) with mustard seed powder (MSP) on improving skin health by evaluating skin physiological and biochemical parameters. This study will test the effect of BSE and MSP compared to placebo on skin health after 4 weeks supplementation. The study will employ a randomized, crossover design with subjects acting as their own controls.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Verify or expand the search:
- PubMed search for NCT05745636
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Inflammation
Currently open trials in the same condition.
- NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
- NCT06750653 — Skin Barrier Function and Inflammation in Aging: The BIA Study · Phase 4 · recruiting
- NCT05535738 — Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation · Phase 2, PHASE3 · recruiting
Other Appalachian State University trials
Trials by the same sponsor.
- NCT07413874 — Telehealth Music Therapy for Adults With Endocrine Disorder and Depression · NA · not yet recruiting
- NCT06495190 — Cognition, Flavonoids, Exercise, Gut Microbiome · NA · recruiting
- NCT06392360 — Betaine, Exercise Performance, and Gut Permeability · NA · completed
- NCT06204666 — Hemp Fiber Ingestion and Gut Permeability After Exercise · NA · completed
- NCT05907135 — Beet Supplementation, Exercise, Inflammation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05745636 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Appalachian State University
- Last refreshed: 20 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05745636.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing